Topics: E-Cigarettes | Smoking Cessation | teens | Vaping

E-cigarettes entered the American market 15 years ago and their use has grown steadily ever since. Dr. Kaliamurthy starts with an overview of vaping technologies, then moves on to discuss the evidence for e-cigarettes as a smoking cessation tool, the new trend of vaping cannabis, and vaping associated health risks.

Topics: Comorbidity | Smoking Cessation | Smoking Cessation Agents

Helping patients with mental illness quit smoking can be particularly challenging; however, there are evidenced based strategies that can help. In this article, we review the evidence for smoking cessation medications in patients with mental illness and highlight some important special considerations.

Topics: Antipsychotic | Meta-analysis | Methamphetamines | Psychosis

In this network meta-analysis, researchers compared different antipsychotics head-to-head for the treatment of methamphetamine psychosis and found some clear winners are losers.

Topics: Alcohol use disorder | Naltrexone | observational study | Psychopharmacology

Naltrexone has shown efficacy for the treatment of alcohol use disorder in tightly controlled trials. Here, researchers demonstrate the efficacy of naltrexone in a large scale naturalistic study.

Topics: CME Post-Test

The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 1 CME credit.